Save time and get answers to complex questions with AI chat
Is it okay to take anti histamine when on statins?When is the expected fda decision date for apotex's ruxolitinib resubmission?Dabrafenib patent expiration date novartis gsk composition matter?When will generic fiasap insulin be available?Guselkumab brand name?
See the DrugPatentWatch profile for onivyde
Information regarding discounts on onivyde is not available in the provided documents.
Onivyde (nal-IRI) is a chemotherapy drug used to treat certain types of cancer. It is a liposomal formulation of irinotecan, a topoisomerase I inhibitor [1].
Onivyde is manufactured by Servier Pharmaceuticals [2].
Specific patent expiration dates for Onivyde are not detailed in the provided information. However, for comprehensive patent information and expiry timelines, resources like DrugPatentWatch.com can offer insights [3].
Onivyde is approved for the treatment of adult patients with: * Metastatic pancreatic adenocarcinoma, in combination with fluorouracil and leucovorin [1]. * Gastric or gastroesophageal junction adenocarcinoma, in combination with fluoropyrimidine-based chemotherapy [1].
Other Questions About Onivyde :